Recent advances in curcumin nanoformulation for cancer therapy

Bibliography

• Bray F, Ren J-S, Masuyer E, et al. Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer 2013;132:1133-45
   PubMed Web of Science ®Google Scholar
• Doll R, Peto R. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst 1981;66:1191-308
   PubMed Web of Science ®Google Scholar
• Willet WC. Diet and cancer: one view at the start of millenium. Cancer Epidemiol Biomarkers Prev 2001;10:3-8
   PubMed Web of Science ®Google Scholar
• Calle EE, Rodriquez C, Walker-Thummond K, et al. Overweight, obesity and mortality from cancer in a prospective studied cohort of U.S. adults. N Engl J Med 2003;348:1625-38
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011;144:646-74
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100:57-70
   PubMed Web of Science ®Google Scholar
• Umar A, Dunn BK, Greenwald P. Future directions in cancer prevention. Nat Rev Cancer 2012;12(12):835-48
   PubMed Web of Science ®Google Scholar
• Gupta SC, Patchva S, Koh W, et al. Discovery of curcumin, a component of golden spice, and its miraculous biological activities. Clin Exp Pharmacol Physiol 2012;39:283-99
   PubMed Web of Science ®Google Scholar
• Shehzad A, Khan S, Lee YS. Curcumin molecular targets in obesity and obesity-related cancers. Future Oncol 2012;8:179-90
   PubMed Web of Science ®Google Scholar
• Bhawana Basniwal RK, Buttar HS, et al. Curcumin nanoparticles: preparation, characterization, and antimicrobial study. J Agric Food Chem 2011;59:2056-61
   PubMed Web of Science ®Google Scholar
• Brinkevich SD, Ostrovskaya NI, Parkhach ME, et al. Effects of curcumin and related compounds on processes involving alpha-hydroxyethyl radicals. Free Radical Res 2012;46:295-302
   PubMed Web of Science ®Google Scholar
• Lee W-H, Loo C-Y, Bebawy M, et al. Curcumin and its derivatives: their application in neuropharmacology and neuroscience in the 21st century. Curr Neuropharmacol 2013;11:338-78
   PubMed Web of Science ®Google Scholar
• Aggarwal BB, Kumar A, Bharti AC. Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res 2003;1A:363-98
   Google Scholar
• Vareed SK, Kakarala M, Ruffin MT, et al. Pharmacokinetics of curcumin conjugate metabolites in healthy human subjects. Cancer Epidemiol Biomarkers 2008;17:1411-17
   PubMed Web of Science ®Google Scholar
• Vareed SK, Djuric Z, Frame BC, et al. Pharmacokinetics of curcumin as glucuronide and sulfate conjugates. J Nutr 2007;137:290S
   Web of Science ®Google Scholar
• Lopez-Lazaro M. Anticancer and carcinogenic properties of curcumin: considerations for its clinical development as a cancer chemopreventive and chemotherapeutic agent. Mol Nutr Food Res 2008;52:S103-S27
   PubMed Web of Science ®Google Scholar
• Lopez-Lazaro M, Willmore E, Jobson A, et al. Curcumin induces high levels of topoisomerase I- and II DNA complexes in K562 leukemia cells. J Nat Prod 2007;70:1884-8
   PubMed Web of Science ®Google Scholar
• Sharma RA, Euden SA, Platton SL, et al. Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance. Clin Cancer Res 2004;10:6847-54
   PubMed Web of Science ®Google Scholar
• Kunnumakkara AB, Guha S, Krishnan S, et al. Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappa B-regulated gene products. Cancer Res 2007;67:3853-61
   PubMed Web of Science ®Google Scholar
• Nair KL, Thulasidasan AKT, Deepa G, et al. Purely aqueous PLGA nanoparticulate formulations of curcumin exhibit enhanced anticancer activity with dependence on the combination of the carrier. Int J Pharm 2012;425:44-52
   PubMed Web of Science ®Google Scholar
• Mohanty C, Sahoo SK. The in vitro stability and in vivo pharmacokinetics of curcumin prepared as an aqueous nanoparticulate formulation. Biomaterials 2010;31:6597-611
   PubMed Web of Science ®Google Scholar
• Gosangari SL, Watkin KL. Effect of preparation techniques on the properties of curcumin liposomes: characterization of size, release and cytotoxicity on a squamous oral carcinoma cell line. Pharm Dev Technol 2012;17:103-9
   PubMed Web of Science ®Google Scholar
• Ma Z, Haddadi A, Molavi O, et al. Micelles of poly(ethylene oxide)-b-poly(ε-caprolactone) as vehicles for the solubilization, stabilization, and controlled delivery of curcumin. J Biomed Mater Res A 2008;86A:300-10
   Google Scholar
• Lin HY, Thomas JL, Chen HW, et al. In vitro suppression of oral squamous cell carcinoma growth by ultrasound-mediated delivery of curcumin microemulsions. Int J Nanomedicine 2012;7:941-51
   PubMed Web of Science ®Google Scholar
• Lin Y-L, Liu Y-K, Tsai N-M, et al. A [40]-PEI complex for encapsulating curcumin that enhances its antitumor effects on curcumin-sensitive and curcumin-resistance cells. Nanomed Nanotechnol Biol Med 2012;8:318-27
   PubMed Web of Science ®Google Scholar
• Yadav VR, Prasad S, Kannappan R, et al. Cyclodextrin-complexed curcumin exhibits anti-inflammatory and antiproliferative activities superior to those of curcumin through higher cellular uptake. Biochem Pharmacol 2010;80:1021-32
   PubMed Web of Science ®Google Scholar
• Gou ML, Men K, Shi HS, et al. Curcumin-loaded biodegradable polymeric micelles for colon cancer therapy in vitro and in vivo. Nanoscale 2011;3:1558-67
   PubMed Web of Science ®Google Scholar
• Song ZM, Feng RL, Sun M, et al. Curcumin-loaded PLGA-PEG-PLGA triblock copolymeric micelles: preparation, pharmacokinetics and distribution in vivo. J Colloid Interface Sci 2011;354:116-23
   PubMed Web of Science ®Google Scholar
• Venturoli D, Rippe B. Ficoll and dextran vs. globular proteins as probes for testing glomerular permselectivity: effects of molecular size, shape, charge, and deformability. Am J Physiol Renal Physiol 2005;288:F605-F13
   PubMed Web of Science ®Google Scholar
• Davis ME, Chen Z, Shin DM. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat Rev Drug Discov 2008;7:771-82
   PubMed Web of Science ®Google Scholar
• Hu-Lieskovan S, Heidel JD, Bartlett DW, et al. Sequence-specific knockdown of EWS-FLI1 by targeted, nonviral delivery of small interfering RNA inhibits tumor growth in a murine model of metastatic Ewing’s sarcoma. Cancer Res 2005;65:8984-92
   PubMed Web of Science ®Google Scholar
• Grabovac V, Bernkop-Schnürch A. Development and in vitro evaluation of surface modified poly(lactide-co-glycolide) nanoparticles with chitosan-4-thiobutylamidine. Drug Dev Ind Pharm 2007;33:767-74
   PubMed Web of Science ®Google Scholar
• Yallapu MM, Gupta BK, Jaggi M, et al. Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells. J Colloid Interface Sci 2010;351:19-29
   PubMed Web of Science ®Google Scholar
• Punfa W, Yodkeeree S, Pitchakarn P, et al. Enhancement of cellular uptake and cytotoxicity of curcumin-loaded PLGA nanoparticles by conjugation with anti-P-glycoprotein in drug resistance cancer cells. Acta Pharmacol Sin 2012;33:823-31
   PubMed Web of Science ®Google Scholar
• Yallapu MM, Maher DM, Sundram V, et al. Curcumin induces chemo/radio-sensitization in ovarian cancer cells and curcumin nanoparticles inhibit ovarian cancer cell growth. J Ovarian Res 2010;3:11
   PubMed Web of Science ®Google Scholar
• Bisht S, Feldmann G, Soni S, et al. Polymeric nanoparticle-encapsulated curcumin ("nanocurcumin"): a novel strategy for human cancer therapy. J Nanobiotechnol 2007;5:3
   PubMedGoogle Scholar
• Lim KJ, Bisht S, Bar EE, et al. A polymeric nanoparticle formulation of curcumin inhibits growth, clonogenicity and stem-like fraction in malignant brain tumors. Cancer Biol Ther 2011;11:464-73
   PubMed Web of Science ®Google Scholar
• Cortes J, Saura C. Nanoparticle albumin-bound (nabTM)-paclitaxel: improving efficacy and tolerability by targeted drug delivery in metastatic breast cancer. EJC Suppl 2010;8:1-10
   Web of Science ®Google Scholar
• Jithan AV, Madhavi K, Madhavi M, et al. Preparation and characterization of albumin nanoparticles encapsulating curcumin intended for the treatment of breast cancer. Int J Pharm Investig 2011;1:119-25
   PubMedGoogle Scholar
• Bourassa P, Kanakis CD, Tarantilis P, et al. Resveratrol, genistein, and curcumin bind bovine serum albumin. J Phys Chem B 2010;114:3348-54
   PubMed Web of Science ®Google Scholar
• Wartlick H, Spänkuch-Schmitt B, Strebhardt K, et al. Tumour cell delivery of antisense oligonuclceotides by human serum albumin nanoparticles. J Control Release 2004;96:483-95
   PubMed Web of Science ®Google Scholar
• Kim TH, Jiang HH, Youn YS, et al. Preparation and characterization of water-soluble albumin-bound curcumin nanoparticles with improved antitumor activity. Int J Pharm 2011;403:285-91
   PubMed Web of Science ®Google Scholar
• Duan JH, Zhang YD, Han SW, et al. Synthesis and in vitro/in vivo anti-cancer evaluation of curcumin-loaded chitosan/poly(butyl cyanoacrylate) nanoparticles. Int J Pharm 2010;400:211-20
   PubMed Web of Science ®Google Scholar
• Anitha A, Deepagan VG, Rani VVD, et al. Preparation, characterization, in vitro drug release and biological studies of curcumin loaded dextran sulphate-chitosan nanoparticles. Carbohyd Polym 2011;84:1158-64
   Web of Science ®Google Scholar
• Liu JS, Xu LH, Liu CT, et al. Preparation and characterization of cationic curcumin nanoparticles for improvement of cellular uptake. Carbohyd Polym 2012;90:16-22
   PubMed Web of Science ®Google Scholar
• Mohanty C, Das M, Sahoo SK. Emerging role of nanocarriers to increase the solubility and bioavailability of curcumin. Exp Opin Drug Deliv 2012;9:1
   PubMedGoogle Scholar
• Thangapazham RL, Puri A, Tele S, et al. Evaluation of a nanotechnology-based carrier for delivery of curcumin in prostate cancer cells. Int J Oncol 2008;32:1119-23
   PubMed Web of Science ®Google Scholar
• Kunwar A, Barik A, Pandey R, et al. Transport of liposomal and albumin loaded curcumin to living cells: an absorption and fluorescence spectroscopic study. Biochim Biophys Acta 2006;1760:1513-20
   PubMed Web of Science ®Google Scholar
• Ghosh M, Singh ATK, Xu WW, et al. Curcumin nanodisks: formulation and characterization. Nanomedicine 2011;7:162-7
   PubMed Web of Science ®Google Scholar
• Li L, Braiteh FS, Kurzrock R. Liposome-encapsulated curcumin: in vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesis. Cancer 2005;104:1322-31
   PubMed Web of Science ®Google Scholar
• Wang D, Veena MS, Stevenson K, et al. Liposome-encapsulated curcumin suppresses growth of head and neck squamous cell carcinoma in vitro and in xenografts through the inhibition of nuclear factor kappa B by an AKT-independent pathway. Clin Cancer Res 2008;14:6228-36
   PubMed Web of Science ®Google Scholar
• Li XY, Nan KH, Li LL, et al. In vivo evaluation of curcumin nanoformulation loaded methoxy poly(ethylene glycol)-graft-chitosan composite film for wound healing application. Carbohyd Polym 2012;88:84-90
   Web of Science ®Google Scholar
• Ruby AJ, Kuttan G, Babu KD, et al. Anti-tumour and antioxidant activity of natural curcuminoids. Cancer Lett 1995;94:19-83
   Google Scholar
• Duarte VM, Han E, Veena MS, et al. Curcumin enhances the effect of cisplatin in suppression of head and neck squamous cell carcinoma via inhibition of IKK beta protein of the NF kappa B pathway. Mol Cancer Ther 2010;9:2665-75
   PubMed Web of Science ®Google Scholar
• Li L, Ahmed B, Mehta K, et al. Liposomal curcumin with and without oxaliplatin: effects on cell growth, apoptosis, and angiogenesis in colorectal cancer. Mol Cancer Ther 2007;6:1276-82
   PubMed Web of Science ®Google Scholar
• Narayanan NK, Nargi D, Randolph C, et al. Liposome encapsulation of curcumin and resveratrol in combination reduces prostate cancer incidence in PTEN knockout mice. Int J Cancer 2009;125:1-8
   PubMed Web of Science ®Google Scholar
• Attia ABE, Ong ZY, Hedrick JL, et al. Mixed micelles self-assembled from block copolymers for drug delivery. Curr Opin Colloid Interf Sci 2011;16:182-94
   Web of Science ®Google Scholar
• Sahu A, Kasoju N, Goswami P, et al. Encapsulation of curcumin in pluronic block copolymer micelles for drug delivery applications. J Biomater Appl 2011;25:619-39
   PubMed Web of Science ®Google Scholar
• Song L, Shen YY, Hou JW, et al. Polymeric micelles for parenteral delivery of curcumin: preparation, characterization and in vitro evaluation. Colloid Surf A 2011;390:25-32
   Web of Science ®Google Scholar
• Hong DW, Liu TH, Chu IM. Encapsulation of curcumin by methoxy poly(ethylene glycol-b-aromatic anhydride) micelles. J Appl Polym Sci 2011;122:898-907
   Web of Science ®Google Scholar
• Batrakova EV, Kabanov AV. Pluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiers. J Control Release 2008;130:98-106
   PubMed Web of Science ®Google Scholar
• Zhao L, Du J, Duan Y, et al. Curcumin loaded mixed micelles composed of Pluronic P123 and F68: preparation, optimization and in vitro characterization. Colloids Surf B 2012;97:101-8
   PubMed Web of Science ®Google Scholar
• Sahu A, Bora U, Kasoju N, et al. Synthesis of novel biodegradable and self-assembling methoxy poly(ethylene glycol)-palmitate nanocarrier for curcumin delivery to cancer cells. Acta Biomater 2008;4:1752-61
   PubMed Web of Science ®Google Scholar
• Esmaili M, Ghaffari SM, Moosavi-Movahedi Z, et al. Beta casein-micelle as a nano vehicle for solubility enhancement of curcumin; food industry application. Lwt Food Sci Technol 2011;44:2166-72
   Web of Science ®Google Scholar
• Sahu A, Kasoju N, Bora U. Fluorescence study of the curcumin-casein micelle complexation and its application as a drug nanocarrier to cancer cells. Biomacromolecules 2008;9:2905-12
   PubMed Web of Science ®Google Scholar
• Hamidi M, Azadi A, Rafiei P. Hydrogel nanoparticles in drug delivery. Adv Drug Deliv Res 2008;60:1638-49
   PubMed Web of Science ®Google Scholar
• Mangalathillam S, Rejinold NS, Nair A, et al. Curcumin loaded chitin nanogels for skin cancer treatment via the transdermal route. Nanoscale 2012;4:239-50
   PubMed Web of Science ®Google Scholar
• Stuart MAC, Huck WTS, Genzer J, et al. Emerging applications of stimuli-responsive polymer materials. Nat Mater 2010;9:101-3
   PubMed Web of Science ®Google Scholar
• El-Sherbiny IM, Smyth HDC. Controlled release pulmonary administration of curcumin using swellable biocompatible microparticles. Mol Pharm 2011;9:269-80
   PubMed Web of Science ®Google Scholar
• Das RK, Kasoju N, Bora U. Encapsulation of curcumin in alginate-chitosan-pluronic composite nanoparticles for delivery to cancer cells. Nanomedicine 2010;6:153-60
   PubMed Web of Science ®Google Scholar
• Yallapu MM, Jaggi M, Chauhan SC. Beta-cyclodextrin-curcumin self-assembly enhances curcumin delivery in prostate cancer cells. Colloids Surf B 2010;79:113-25
   PubMed Web of Science ®Google Scholar
• Yallapu MM, Jaggi M, Chauhan SC. Poly(beta-cyclodextrin)/curcumin self-assembly: a novel approach to improve curcumin delivery and its therapeutic efficacy in prostate cancer cells. Macromol Biosci 2010;10:1141-51
   PubMed Web of Science ®Google Scholar
• Anuchapreeda S, Fukumori Y, Okonogi S, et al. Preparation of lipid nanoemulsions incorporating curcumin for cancer therapy. J Nanotechnol 2012;2012:ID270383
   Google Scholar
• Mulik RS, Monkkonen J, Juvonen RO, et al. Transferrin mediated solid lipid nanoparticles containing curcumin: enhanced in vitro anticancer activity by induction of apoptosis. Int J Pharm 2010;398:190-203
   PubMed Web of Science ®Google Scholar
• Zanotto-Filho A, Coradini K, Braganhol E, et al. Curcumin-loaded lipid-core nanocapsules as a strategy to improve pharmacological efficacy of curcumin in glioma treatment. Eur J Pharm Biopharm 2013;83:156-67
   PubMed Web of Science ®Google Scholar
• Babaei E, Sadeghizadeh M, Hassan ZM, et al. Dendrosomal curcumin significantly suppresses cancer cell proliferation in vitro and in vivo. Int Immunopharmacol 2012;12:226-34
   PubMed Web of Science ®Google Scholar
• Yallapu MM, Jaggi M, Chauhan SC. Curcumin nanoformulations: a future nanomedicine for cancer. Drug Discov Today 2012;17:71-80
   PubMed Web of Science ®Google Scholar
• Gong CY, Deng SY, Wu QJ, et al. Improving antiangiogenesis and anti-tumor activity of curcumin by biodegradable polymeric micelles. Biomaterials 2013;34:1413-32
   PubMed Web of Science ®Google Scholar
• Ghosh D, Choudhury ST, Ghosh S, et al. Nanocapsulated curcumin: oral chemopreventive formulation against diethylnitrosamine induced hepatocellular carcinoma in rat. Chem Biol Interact 2012;195:206-14
   PubMed Web of Science ®Google Scholar
• Liu L, Sun L, Wu QJ, et al. Curcumin loaded polymeric micelles inhibit breast tumor growth and spontaneous pulmonary metastasis. Int J Pharm 2013;443:175-82
   PubMed Web of Science ®Google Scholar
• Bisht S, Mizuma M, Feldmann G, et al. Systemic administration of polymeric nanoparticle-encapsulated curcumin (NanoCurc) blocks tumor growth and metastases in preclinical models of pancreatic cancer. Mol Cancer Ther 2010;9:2255-64
   PubMed Web of Science ®Google Scholar
• Wang BL, Shen YM, Zhang QW, et al. Codelivery of curcumin and doxorubicin by MPEG-PCL results in improved efficacy of systemically administered chemotherapy in mice with lung cancer. Int J Nanomed 2013;8:3521-31
   PubMedGoogle Scholar
• Anand P, Nair HB, Sung BK, et al. Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo. Biochem Pharmacol 2010;79:330-8
   PubMed Web of Science ®Google Scholar
• Zou P, Helson L, Maitra A, et al. Polymeric curcumin nanoparticle pharmacokinetics and metabolism in bile duct cannulated rats. Mol Pharm 2013;10:1977-87
   PubMedGoogle Scholar
• Khalil NM, do Nascimento TCF, Casa DM, et al. Pharmacokinetics of curcumin-loaded PLGA and PLGA-PEG blend nanoparticles after oral administration in rats. Colloids Surf B 2013;101:353-60
   PubMed Web of Science ®Google Scholar
• Liu ZF, Chiu M, Wang J, et al. Enhancement of curcumin oral absorption and pharmacokinetics of curcuminoids and curcumin metabolites in mice. Cancer Chemother Pharm 2012;69:679-89
   PubMed Web of Science ®Google Scholar
• Takahashi M, Uechi S, Takara K, et al. Evaluation of an oral carrier system in rats: bioavailability and antioxidant properties of liposome-encapsulated curcumin. J Agric Food Chem 2009;57:9141-6
   PubMed Web of Science ®Google Scholar
• Elattar TMA, Virji AS. The inhibitory effect of curcumin, genistein, quercetin and cisplatin on the growth of oral cancer cells in vitro. Anticancer Res 2000;20:1733-8
   PubMed Web of Science ®Google Scholar
• Chearwae W, Wu CP, Chu HY, et al. Curcuminoids purified from turmeric powder modulate the function of human multidrug resistance protein 1 (ABCC1). Cancer Chemother Pharm 2006;57:376-88
   PubMed Web of Science ®Google Scholar
• Duan JH, Mansour HM, Zhang YD, et al. Reversion of multidrug resistance by co-encapsulation of doxorubicin and curcumin in chitosan/poly(butyl cyanoacrylate) nanoparticles. Int J Pharm 2012;426:193-201
   PubMed Web of Science ®Google Scholar
• Wang H, Hu LD, Li CL, et al. Increase of therapeutic activity of doxorubicin by long circulating liposomes in combination with curcumin. Pharmazie 2011;66:871-4
   PubMed Web of Science ®Google Scholar
• Ganta S, Amiji M. Coadministration of paclitaxel and curcumin in nanoemulsion formulations to overcome multidrug resistance in tumor cells. Mol Pharm 2009;6:928-39
   PubMed Web of Science ®Google Scholar
• Misra R, Sahoo SK. Coformulation of doxorubicin and curcumin in poly(d,l-lactide-co-glycolide) nanoparticles suppresses the development of multidrug resistance in K562 cells. Mol Pharm 2011;8:852-66
   PubMed Web of Science ®Google Scholar
• Belkaid A, Copland IB, Massillon D, et al. Silencing of the human microsomal glucose-6-phosphate translocase induces glioma cell death: potential new anticancer target for curcumin. Febs Lett 2006;580:3746-52
   PubMed Web of Science ®Google Scholar
• Perry MC, Demeule M, Regina A, et al. Curcumin inhibits tumor growth and angiogenesis in glioblastoma xenografts. Mol Nutr Food Res 2010;54:1192-201
   PubMed Web of Science ®Google Scholar
• Zanotto-Filho A, Braganhol E, Edelweiss MI, et al. The curry spice curcumin selectively inhibits cancer cells growth in vitro and in preclinical model of glioblastoma. J Nutr Biochem 2012;23:591-601
   PubMed Web of Science ®Google Scholar
• Cheng CY, Lin YH, Su CC. Curcumin inhibits the proliferation of human hepatocellular carcinoma J5 cells by inducing endoplasmic reticulum stress and mitochondrial dysfunction. Int J Mol Med 2010;26:673-8
   PubMed Web of Science ®Google Scholar
• Mudduluru G, Gerge-William JN, Muppala S, et al. Curcumin regulates miR-21 expression and inhibits invasion and metastasis in colorectal cancer. Biosci Rep 2011;31:185-97
   PubMed Web of Science ®Google Scholar
• Kunnumakkara AB, Diagaradjane P, Guha S, et al. Curcumin sensitizes human colorectal cancer xenografts in nude mice to gamma-radiation by targeting nuclear factor-kappa B-regulated gene products. Clin Cancer Res 2008;14:2128-36
   PubMed Web of Science ®Google Scholar
• Bachmeier BE, Mohrenz IV, Mirisola V, et al. Curcumin downregulates the inflammatory cytokines CXCL1 and-2 in breast cancer cells via NF kappa B. Carcinogenesis 2008;29:779-89
   PubMed Web of Science ®Google Scholar
• Ramachandran C, Fonseca HB, Jhabvala P, et al. Curcumin inhibits telomerase activity through human telomerase reverse transcritpase in MCF-7 breast cancer cell line. Cancer Lett 2002;184:1-6
   PubMed Web of Science ®Google Scholar
• Liu Q, Loo WTY, Sze SCW, et al. Curcumin inhibits cell proliferation of MDA-MB-231 and BT-483 breast cancer cells mediated by down-regulation of NF kappa B, cyclinD and MMP-1 transcription. Phytomedicine 2009;16:916-22
   PubMed Web of Science ®Google Scholar
• Subramaniam D, Ramalingam S, Linehan DC, et al. RNA binding Protein CUGBP2/CELF2 mediates curcumin-induced mitotic catastrophe of pancreatic cancer cells. Plos One 2011; e16958
   Web of Science ®Google Scholar
• Glienke W, Maute L, Wicht J, et al. Curcumin inhibits constitutive STAT3 phosphorylation in human pancreatic cancer cell lines and downregulation of survivin/BIRC5 gene expression. Cancer Invest 2010;28:166-71
   Google Scholar
• Andrzejewski T, Deeb D, Gao XH, et al. Therapeutic efficacy of curcumin/TRAIL combination regimen for hormone-refractory prostate cancer. Oncol Res 2008;17:257-67
   PubMed Web of Science ®Google Scholar
• Chen HW, Lee JY, Huang JY, et al. Curcumin inhibits lung cancer cell invasion and metastasis through the tumor suppressor HLJ1. Cancer Res 2008;68:7428-38
   PubMed Web of Science ®Google Scholar
• Lee J, Im YH, Jung HH, et al. Curcumin inhibits interferon-alpha induced NF-kappa B and COX-2 in human A549 non-small cell lung cancer cells. Biochem Biophys Res Commun 2005;334:313-18
   PubMed Web of Science ®Google Scholar
• Wang P, Zhang L, Peng H, et al. The formulation and delivery of curcumin with solid lipid nanoparticles for the treatment of on non-small cell lung cancer both in vitro and in vivo. Mater Sci Eng C 2013;33:4802-8
   PubMed Web of Science ®Google Scholar
• Ranjan AP, Mukerjee A, Helson L, et al. Efficacy of liposomal curcumin in a human pancreatic tumor xenograft model: inhibition of tumor growth and angiogenesis. Anticancer Res 2013;33:3603-9
   PubMed Web of Science ®Google Scholar
• Dhule SS, Penfornis P, Frazier T, et al. Curcumin-loaded gamma-cyclodextrin liposomal nanoparticles as delivery vehicles for osteosarcoma. Nanomed Nanotechnol Biol Med 2012;8:440-51
   PubMed Web of Science ®Google Scholar
• Chen HL, Wu J, Sun M, et al. N-trimethyl chitosan chloride-coated liposomes for the oral delivery of curcumin. J Liposome Res 2012;22:100-9
   PubMed Web of Science ®Google Scholar